NDC 72934-2030

CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2%

Calcipotriene 0.005% / Diclofenac Sodium 3% / Hyaluronic Acid Sodium Salt 2% / Niacinamide 2%

CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2% is a Topical Cream in the Human Prescription Drug category. It is labeled and distributed by Sincerus Florida, Llc. The primary component is Calcipotriene; Diclofenac Sodium; Hyaluronate Sodium; Niacinamide.

Product ID72934-2030_883e1f59-2a7b-1ccd-e053-2995a90a1ef0
NDC72934-2030
Product TypeHuman Prescription Drug
Proprietary NameCALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2%
Generic NameCalcipotriene 0.005% / Diclofenac Sodium 3% / Hyaluronic Acid Sodium Salt 2% / Niacinamide 2%
Dosage FormCream
Route of AdministrationTOPICAL
Marketing Start Date2019-05-07
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameSincerus Florida, LLC
Substance NameCALCIPOTRIENE; DICLOFENAC SODIUM; HYALURONATE SODIUM; NIACINAMIDE
Active Ingredient Strength0 g/100g; g/100g; g/100g; g/100g
Pharm ClassesVitamin D [CS],Vitamin D Analog [EPC],Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 72934-2030-2

30 g in 1 BOTTLE, PUMP (72934-2030-2)
Marketing Start Date2019-05-07
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72934-2030-2 [72934203002]

CALCIPOTRIENE 0.005% / DICLOFENAC SODIUM 3% / HYALURONIC ACID SODIUM SALT 2% / NIACINAMIDE 2% CREAM
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2019-05-07

Drug Details

Active Ingredients

IngredientStrength
CALCIPOTRIENE.005 g/100g

Pharmacological Class

  • Vitamin D [CS]
  • Vitamin D Analog [EPC]
  • Cyclooxygenase Inhibitors [MoA]
  • Decreased Prostaglandin Production [PE]
  • Anti-Inflammatory Agents
  • Non-Steroidal [CS]
  • Nonsteroidal Anti-inflammatory Drug [EPC]
  • Vitamin D [CS]
  • Vitamin D Analog [EPC]
  • Cyclooxygenase Inhibitors [MoA]
  • Decreased Prostaglandin Production [PE]
  • Anti-Inflammatory Agents
  • Non-Steroidal [CS]
  • Nonsteroidal Anti-inflammatory Drug [EPC]

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.